There is also a need to better understand whether the BMI/body composition associations differ between specific BC subtypes (e.g., HER2 positive/negative versus triple-negative BC, ER/PR negative versus ER/PR positive), advanced cancer types (e.g., BC versus lung cancer) and received cancer treatments. This evidence concerns the gene ERBB2 and lung carcinoma.